These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17108215)

  • 21. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
    Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
    Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
    Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
    J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of an array comparative genomic hybridization (CGH) technique in detecting DNA copy number aberrations: comparison with conventional CGH and loss of heterozygosity analysis in prostate cancer.
    Yano S; Matsuyama H; Matsuda K; Matsumoto H; Yoshihiro S; Naito K
    Cancer Genet Cytogenet; 2004 Apr; 150(2):122-7. PubMed ID: 15066319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
    Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
    Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
    Tabarés G; Radcliffe CM; Barrabés S; Ramírez M; Aleixandre RN; Hoesel W; Dwek RA; Rudd PM; Peracaula R; de Llorens R
    Glycobiology; 2006 Feb; 16(2):132-45. PubMed ID: 16177264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor-beta 1 gene polymorphisms and expression in the blood of prostate cancer patients.
    Faria PC; Saba K; Neves AF; Cordeiro ER; Marangoni K; Freitas DG; Goulart LR
    Cancer Invest; 2007 Dec; 25(8):726-32. PubMed ID: 18058470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients.
    Beneduce L; Prayer-Galetti T; Giustinian AM; Gallotta A; Betto G; Pagano F; Fassina G
    Cancer Detect Prev; 2007; 31(5):402-7. PubMed ID: 18035503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
    Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O
    Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of mesenteric and peripheral blood circulating tumor DNA in colorectal cancer patients.
    Taback B; Saha S; Hoon DS
    Ann N Y Acad Sci; 2006 Sep; 1075():197-203. PubMed ID: 17108212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease.
    Shafer MW; Mangold L; Partin AW; Haab BB
    Prostate; 2007 Feb; 67(3):255-67. PubMed ID: 17192876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Frequent allelic losses in tumor-associated stromal cells and tumor epitelium of prostate cancer].
    Kekeeva TV; Popova OP; Shegaĭ PV; Zavalishina LE; Andreeva IuIu; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2008; 42(1):96-101. PubMed ID: 18389625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels.
    Licastro F; Bertaccini A; Porcellini E; Chiappelli M; Pernetti R; Sanguedolce F; Marchiori D; Martorana G
    Anticancer Res; 2008; 28(1B):395-9. PubMed ID: 18383875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer.
    Huang YC; Lee CM; Chen M; Chung MY; Chang YH; Huang WJ; Ho DM; Pan CC; Wu TT; Yang S; Lin MW; Hsieh JT; Chen YM
    Clin Cancer Res; 2007 Mar; 13(5):1412-20. PubMed ID: 17332283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of plasma interleukin-8 concentration in patients with prostate cancer and benign prostate hyperplasia.
    Dehghani M; Mostafavi-Pour Z; Lotfi M; Shakeri S
    Iran J Immunol; 2009 Jun; 6(2):92-8. PubMed ID: 19561378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological aspects of prostate cancer and benign nodular hyperplasia.
    Wernert N; Bieroff E; Hügel A
    Anticancer Res; 1997; 17(4B):2907-10. PubMed ID: 9329560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Loss of heterozygosity on chromosome 10 is associated with bone metastasis of human prostate cancer].
    Hou Z; Luo Y; Jiang YG; Li MC; Lin YH; Zhang YP
    Zhonghua Nan Ke Xue; 2008 Oct; 14(10):879-83. PubMed ID: 19157094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Differentially expressed genes in prostate cancer and benign prostatic hyperplasia].
    Zhang T; Xu Y; Tang H; Liu M; Ren D; Niu Y
    Zhonghua Nan Ke Xue; 2004 Dec; 10(12):897-9. PubMed ID: 15638016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion at chromosome arms 6q16-22 and 10q22.3-23.1 associated with initiation of prostate cancer.
    Lu T; Hano H
    Prostate Cancer Prostatic Dis; 2008; 11(4):357-61. PubMed ID: 18227855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deoxyribonuclease activity and circulating DNA concentration in blood plasma of patients with prostate tumors.
    Cherepanova AV; Tamkovich SN; Bryzgunova OE; Vlassov VV; Laktionov PP
    Ann N Y Acad Sci; 2008 Aug; 1137():218-21. PubMed ID: 18837950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.